Take a look at three predictions for the year ahead for pharma executives considering AI implementation and adoption. For AI ...

With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.

Though the United States is the global leader in designing chips, the vast majority of chip production happens overseas.

Wen Shuhao helped speed up the development of Pfizer’s Covid oral drug, Paxlovid. Now the chairman of Xtalpi wants to help ...

Lantern Pharma Inc. (NASDAQ ... with some already validated for use. The AI-powered ADC module could speed up drug development by up to 50% and lower costs by 60%. It would also reduce both ...

The Indiana University McKinney School of Law is adding a new symposium to its roster, focused on how leaders can work with, ...

We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street’s Radar. In this article, we are going to take a ...

This study reinforces the significance of intensive glycaemic control and is a paradigm shift in managing the disease and its ...

Via AI methodologies, trial sponsors can simulate outcomes for different clinical development pathway scenarios to evaluate ...